실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

8,428+프로그램
40+FDA 승인
3,743+모집 중
ADC 1032·Antibody 4683·CGT 2713차세대 추천 →·Data Tier →
8428프로그램40FDA 승인
374오늘 방문
6,137누적 방문
7303갱신 대기S–CData TierS/A/B차세대→Insight1032HER2 breast4683Antibody2713CGT→Psoriasis→NSCLC40FDA 승인
피드Data Tier차세대Insight

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · EbglyssPCSK9 · LDLRepatha · Praluent · LeqvioGLP-1 · incretinSemaglutide · Tirzepatide혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
다음 갱신 D-6 · 마지막 7월 21일
AntibodystaleAmgenPhase 1

acapatamab (acapatamab)

Metastatic Castration-resistant Prostate Cancer; Prostate Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#Antibody#Phase1#항체#면역항체+3
임상시험 2상태 DISCONTINUED
ADCBiologicstaleGlaxoSmithKlinePhase 1

Ris-Rez (Ris-Rez)

Neoplasms · Neoplasms, Lung

#NeoplasmsLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleEli Lilly and CompanyPhase 1

LY4170156 (LY4170156)

Ovarian Neoplasms; Endometrial Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Bicalutamide)

Extramammary Paget Disease; Scrotum Disease · Extramammary Paget Disease

#ExtramammaryPagetDisease#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 1

FPI-2053 (FPI-2053)

Advanced Solid Tumor; Metastatic Colorectal Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Niraparib + Nivolumab)

Pancreatic Adenocarcinoma · Pancreatic Adenocarcinoma

#PancreaticAdenocarcinoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 7.7%임상시험 2상태 ACTIVE
AntibodystalePfizerPhase 2

Elranatamab-bcmm (Elranatamab-bcmm)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING
CGTBiologicstaleKevin FlaniganPhase 2

rAAVrh74.MCK.GALGT2 (rAAVrh74.MCK.GALGT2)

Duchenne Muscular Dystrophy · Duchenne Muscular Dystrophy

#DuchenneMuscularDystrophy#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 2상태 ACTIVE
AntibodystaleBeiGenePhase 3

Ociperlimab (Ociperlimab)

Advanced Hepatocellular Carcinoma · FRα

#FR#Antibody#Phase3#항체#면역항체+3
효능 ORR 100%임상시험 2상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

CDX-3379 and cetuximab (CDX-3379 and cetuximab)

Advanced Head and Neck Squamous Cell Carcinoma · Advanced Head and Neck Squamous Cell Car

#AdvancedHeadandNeckSquamousCellC#Antibody#Phase2#항체#면역항체+2
효능 ORR 7%임상시험 2상태 DISCONTINUED
CGTBiologicstaleBeacon TherapeuticsPhase 2

rAAV1-CB-hAAT (rAAV1-CB-hAAT)

Alpha-1 Antitrypsin Deficiency · Alpha 1-Antitrypsin Deficiency

#Alpha1-AntitrypsinDeficiency#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
AntibodystaleHoffmann-La RocheApproved

Daclizumab (Daclizumab)

Type 1 Diabetes Mellitus · Myelodysplastic Syndromes

#MyelodysplasticSyndromes#Antibody#Approved#항체#면역항체+3
효능 ORR 20%임상시험 2상태 ACTIVE
ADCBiologicstaleAbbViePhase 1

ABBV-838 (ABBV-838)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 DISCONTINUED
CGTBiologicstaleShenzhen Geno-Immune Medical In…Preclinical

Intrathecal and intravenous LV gene therapy (Intrathecal and intravenous LV gene therapy)

X-linked Adrenoleukodystrophy · Metachromatic Leukodystrophy (MLD)

#MetachromaticLeukodystrophyMLD#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

HF10 plus Ipilimumab (HF10 plus Ipilimumab)

Malignant Melanoma · Malignant Melanoma

#MalignantMelanoma#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 ACTIVE
CGTBiologicstaleNanoscope Therapeutics Inc.Phase 2

Gene Therapy product:vMCO-I (Gene Therapy product:vMCO-I)

Retinitis Pigmentosa; Retinal Diseases · Retinitis Pigmentosa

#RetinitisPigmentosa#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
ADCBiologicstaleSeagen Inc.Phase 1

SGN-75 (SGN-75)

Renal Cell Carcinoma · Carcinoma, Renal Cell

#CarcinomaRenalCell#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 DISCONTINUED
CGTBiologicstaleM.D. Anderson Cancer CenterPhase 2

TGFBR2 KO CAR27/IL-15 NK cells (TGFBR2 KO CAR27/IL-15 NK cells)

Gastric Cancer, Metastatic · Lymphoid

#Lymphoid#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 1

ASG-5ME (ASG-5ME)

Gastric Neoplasms; Pancreatic Neoplasms · Gastric Neoplasms

#GastricNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE
ADCBiologicstaleBayerSN-38, which is predominant…Phase 1

BAY 3547922 (BAY 3547922)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

atezolizumab (Tecentriq, YL201 and atezolizumab)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

Dual-target CAR-NK cells (Dual-target CAR-NK cells)

Malignant Glioma; High-Grade Gliomas · Malignant Glioma

#MalignantGlioma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleGuangdong Xiangxue Precision Me…Phase 2

NY-ESO-1（TCR Affinity Enhancing Specific T cell Therapy） (NY-ESO-1（TCR Affinity Enhancing Specific T cell Therapy）)

Soft Tissue Sarcoma · Bone Sarcoma

#BoneSarcoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 1

T-cell Receptor-engineered T-cells (T-cell Receptor-engineered T-cells)

Prostate Carcinoma; Prostate Small Cell Neuroendocrine Carcinoma · Metastatic Malignant Solid Neoplasm

#MetastaticMalignantSolidNeoplasm#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 32%임상시험 2상태 RECRUITING
CGTBiologicstaleHenan Academy of Innovations in…Phase 1

Autologous NK cells (Autologous NK cells)

Malignant Solid Brain Tumors; Glioblastoma (GBM) · Malignant Solid Brain Tumors

#MalignantSolidBrainTumors#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 0.667%임상시험 2상태 ACTIVE

53 / 142 페이지

← 이전다음 →
전체 8,428개 프로그램 보기